Galectin Therapeutics (GALT) Receives Patent for GR-MD-02 Patent for Method and Treatment of Pulmonary Fibrosis

  1. Galectin Therapeutics (GALT) Receives Patent for GR-MD-02 Patent for Method and Treatment of Pulmonary Fibrosis  StreetInsider.com

  2. Small-Cap Snapshot: Galectin Therapeutics flies after receiving a patent for treating pulmonary fibrosis  Proactive Investors USA & Canada

    3. Full coverage